Bormioli Pharma
Pierfrancesco Stabile is an experienced professional in the plastic product industrialization field, currently serving as Head of Plastic Product Industrialization at Bormioli Pharma since September 2023. Prior experience includes roles as Molding Process Manager at DENSO Thermal Systems S.p.A. from May 2015 to August 2023, where responsibilities encompassed the technical management of injection molding processes, process optimization, and mold maintenance. Pierfrancesco also held positions at CNH Industrial and Eltek Group, focusing on process industrialization, design reviews, and troubleshooting. Earlier roles include technical and production management at Serraino tecnopolimeri and supervisory duties at ACS DOBFAR. Educational qualifications comprise a Master's degree in Plastic Engineering from Politecnico di Torino, a General Manager Master from Salerno Formazione, and a degree in Chemistry from Università degli Studi di Salerno.
This person is not in any teams
Bormioli Pharma
Established in 1825, Bormioli Pharma is a leading Italian pharma primary packaging manufacturer. Bormioli Pharma works closely with the pharmaceutical industry and all companies that are working towards the future of healthcare globally. As a world-renowned player in the packaging industry, the company serves the pharmaceutical and biopharmaceutical markets with complete solutions, including glass and plastic bottles, plastic and aluminum closures and accessories. Bormioli Pharma’s wide product ranges are designed and manufactured looking forward innovation and addressing ever-growing sustainability issues. Moreover, each product is specifically conceived for the destination market thanks to an accurate portfolio segmentation. Bormioli Pharma has a global presence in over 100 countries, with more than 1,400 employees and 9 plants across Europe specialized in the production of glass and plastic packaging. Each year, the company produces more than 7 billion pieces and in 2022 reported annual sales of approximately 315 million euros. As a partner to the pharmaceutical industry, Bormioli Pharma invests and innovates with one goal in mind: making health a positive practice, available to everyone, kind to the planet.